Up-regulation of Foxp3 participates in progression of cervical cancer

Cancer Immunology, Immunotherapy

Volumn 62, Issue 3, 2013, Pages 481-487

  Zeng, Chao ^a   Yao, Yunhong ^a   Jie, Wei ^a   Zhang, Miao ^c   Hu, Xinrong ^a   Zhao, Yi ^d   Wang, Sen ^a   Yin, Jinbao ^a   Song, Yulan ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c Xin Hui Maternity and Child Health Care Hospital   (China)

^d GGuangdong Medical College   (China)

Author keywords

Cervical cancer; Differentiation; Foxp3; P16INK4a

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKERATIN 10; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GROWTH; CANCER SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR DIFFERENTIATION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DNA CELL DNA INTERACTION; DISEASE COURSE; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84877102328     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1348-8     Document Type: Article

References (26)

1. Parkin D, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24:S11-S25 (Pubitemid 44404053)
2. Dehn D, Torkko KC, Shroyer KR (2007) Human Papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 111:1-14 (Pubitemid 46281079)
3. Coffer PJ, Burgering BM (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4:889-899 (Pubitemid 39490764)
4. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329-341 (Pubitemid 40387475)
5. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061 (Pubitemid 36222930)
6. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756-2761 (Pubitemid 34921025)
7. + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423-5434 (Pubitemid 44497257)
8. + regulatory T cells in patients with hepatocellular carcinoma. Eur J Surg Oncol 34:173-179
9. Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grüssel S, Sipos B, Grützmann R, Pilarsky C, Ungefroren H, Saeger HD, Klöppel G, Kabelitz D, Kalthoff H (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67:8344-8350 (Pubitemid 47395173)
10. Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Mènard S, Tagliabue E, Balsari A (2009) FOXP3 expression and overall survival in breast cancer. J Clin Oncol 27:1746-1752
11. Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, Zheng P, Liu Y (2007) FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 117:3765-3773 (Pubitemid 350224087)
12. Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P (2009) Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 16:336-346
13. Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457-462 (Pubitemid 46605910)
14. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-352 (Pubitemid 41716771)
15. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562 (Pubitemid 38680433)
16. Zhang HY, Sun H (2010) Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett 28:791-797
17. Cunha LL, Morari EC, Nonogaki S, Soares FA, Vassallo J, Ward LS (2012) Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas. Clinics 67:483-488
18. Wang LH, Lin S, Wang JT (2010) Correlation between elevated FOXP3 expression and increase lymph node metastasis of gastric cancer. Chin Med J 123:3545-3549
19. Niu J, Jiang C, Li C, Liu L, Li K, Jian Z, Gao T (2011) Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction. Cancer Immunol Immunother 60:1109-1118
20. Tao H, Mimura Y, Aoe K, Kobayashi S, Yamamoto H, Matsuda E, Okabe K, Matsumoto T, Sugi K, Ueoka H (2012) Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer 75:95-101
21. Karube K, Aoki R, Sugita Y, Yoshida S, Nomura Y, Shimizu K, Kimura Y, Hashikawa K, Takeshita M, Suzumiya J, Utsunomiya A, Kikuchi M, Ohshima K (2008) The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma. Mod Pathol 21:617-625 (Pubitemid 351589656)
22. Bolzer K, Käser T, Saalmüller A, Hammer SE (2009) Molecular characterisation of porcine Forkhead-box p3 (Foxp3). Vet Immunol Immunopathol 132:275-281
23. Boisvieux-Ulrich E, Le Pechon-Vallée C, Million K, Baeza-Squiban A, Houcine O, Guennou C, Reichert U, Marano F (2000) Differential effects of several retinoid receptor-selective ligands on squamous differentiation and apoptosis in airway epithelial cells. Cell Tissue Res 300:67-81 (Pubitemid 30209765)
24. Wang WH, Jiang CL, Yan W, Zhang YH, Yang JT, Zhang C, Yan B, Zhang W, Han W, Wang JZ, Zhang YQ (2010) FOXP3 expression and clinical characteristics of hepatocellular carcinoma. World J Gastroenterol 16:5502-5509
25. Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR (2008) Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study. Cancer 114:474-480
26. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M (2002) p16 immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389-1399 (Pubitemid 35239415)